Jazz Pharmaceuticals plc Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Jazz Pharmaceuticals plc (JAZZ) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $101.20 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-24
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $101.20M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $86.80M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $77.10M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $91.70M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-12-31 | $101.20M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $86.80M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $77.10M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $91.70M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $82.00M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $93.00M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $78.80M 10-K · filed 2021-02-23 | |
| 2018-12-31 | $78.50M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $73.50M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $61.00M 10-K · filed 2018-02-27 | $65.30M 10-K · filed 2017-02-28 |
| 2015-12-31 | $48.10M 10-K · filed 2017-02-28 | |
| 2014-12-31 | $29.70M 10-K · filed 2016-02-23 | |
| 2013-12-31 | $16.30M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |